IVF or ICSI: what is the difference and when does the clinic choose which?

The clinic tells you it will be ICSI. Nobody explains why. You nod, you walk out, and at home you start searching.

What usually gets left out is the part that matters. ICSI is not a different treatment from IVF. It is a lab technique inside IVF.

Same hormone stimulation, same egg retrieval, same transfer. The difference sits in the dish.

My position, and I will defend it below: this choice deserves an explanation, not alarm. In couples without a male factor, ICSI has no demonstrated advantage.

What is the difference between IVF and ICSI?

In conventional IVF your egg and thousands of sperm cells are placed together in a dish. Fertilisation happens on its own. In ICSI the embryologist picks a single sperm cell and injects it straight into the egg with a fine needle. Everything around that step stays the same.

So in IVF the sperm cell does the work. It has to get through the outer layer of the egg itself. In ICSI the embryologist takes that job over.

For your body, nothing changes. You take the same medication. You go through the same egg retrieval. The embryo goes back the same way.

The full route is mapped out in what IVF is and how the trajectory works.

IVF and ICSI side by side

A table says more here than a story. Watch the rows that are identical.

Four of the eight rows are literally the same. Your body notices very little of this choice.

The lab does notice. That is exactly where the debate sits.

When does a clinic choose ICSI?

ICSI was designed for a male factor. Few sperm cells, slow movement, an unusual shape, or sperm collected surgically. Clinics also choose ICSI after a previous cycle in which no egg fertilised. Your clinic weighs your own results, not a blanket rule.

In practice these reasons come back:

• A low sperm count, or sperm with poor movement.
• Sperm collected through a surgical procedure.
• A previous IVF cycle with no fertilisation.
• Few eggs, so the clinic does not want to waste one.
• Eggs that were frozen and thawed.

Those last two are interesting. There is no male factor there. ICSI gets picked out of caution.

For some couples, IUI comes first. Only when that fails does IVF or ICSI follow.

Why ICSI without a male factor shows no demonstrated advantage

This is the uncomfortable part. ICSI is often used when there is no male factor. Cochrane looked at exactly that group: couples with a normal sperm count and normal motility. The chance of a live birth was not measurably higher with ICSI. The certainty of that evidence is low, so this is not proof of equivalence.

The numbers: a risk ratio of 1.11 for live birth, with a confidence interval of 0.94 to 1.30 (PMID 37581383). That interval runs straight through 1. It rests on two studies and 1,124 couples. That is thin.

So the wording matters. No demonstrated advantage does not mean the two are equal. It mostly means we do not know well enough yet.

Why does it still happen so often? Partly out of habit. Partly because a failed fertilisation lands hard, and ICSI feels like it shrinks that risk. That is human. It is simply not evidence.

For context, the Dutch NHG guideline on subfertility only speaks of subfertility after twelve months of unprotected intercourse without pregnancy. Thuisarts uses the same threshold.

What can your blood values say about this?

Little about the choice itself. That call is mostly about the sperm and about earlier fertilisation. What your blood does show is how your ovaries are likely to respond to the stimulation. Clinics read that from AMH, FSH and estradiol, usually alongside an ultrasound scan.

AMH gives an estimate of your egg reserve. The antral follicle count does the same thing with a scan. A meta-analysis compared both for predicting ovarian response and found no clear difference in predictive value (PMID 37370145). They complement each other.

If you want to know what is actually measured, read on about AMH, FSH and estradiol. What an AMH result means at your age sits in the article on AMH values by age.

We are a lab, not a clinic. We measure, the clinic decides.

Does the choice change your success rate?

Less than you might fear, and that is good news. Your odds track mostly with your age, with the number of eggs collected and with how many cycles you do. A large cohort of almost 157,000 women found a live birth rate of 32.3 percent in the first cycle under forty.

In women aged 40 to 42, that same study put the first-cycle chance at 12.3 percent (PMID 26717030). Across repeat cycles the cumulative chance kept climbing. That is the heart of the paper.

Say you and another couple both get 8 eggs at retrieval. One of you has conventional IVF. The other gets ICSI, because of a low sperm count.

Your odds are shaped mostly by those eggs and by your age. Not by the technique in the dish.

What else moves your odds per attempt sits in IVF success rates per cycle.

What I would ask in the consulting room

I would not argue about the technique. I would ask for the reason. Ask which finding tipped the decision: the sperm result, an earlier cycle, or simply clinic policy. Ask what the lab expects from fertilisation. A good answer takes about two minutes.

I find honesty kinder here than reassurance. ICSI is not an upgrade. It is a fix for a specific problem.

If you have no male factor, you may ask why the injection is being done anyway. That is a fair question, not distrust. A good clinic explains it calmly.

Starting soon? Check first which hormone values your clinic already holds. If they are missing, you can have them measured yourself with the IVF blood test or the broader IVF blood test complete. If you are still at the beginning, the fertility assessment can be a calmer place to start.

References

1. Cutting E, Horta F, Dang V, van Rumste MME, Mol BWJ. Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility. Cochrane Database Syst Rev. 2023;8(8):CD001301. PMID 37581383.
2. Smith ADAC, Tilling K, Nelson SM, Lawlor DA. Live-Birth Rate Associated With Repeat In Vitro Fertilization Treatment Cycles. JAMA. 2015;314(24):2654-2662. PMID 26717030.
3. Liu Y, Pan Z, Wu Y, Song J, Chen J. Comparison of anti-Mullerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis. J Ovarian Res. 2023. PMID 37370145.
4. NHG and Thuisarts. NHG guideline on subfertility and public information on fertility testing. Available via thuisarts.nl.

Every blood test result at Lunara includes a professional assessment by a BIG-registered doctor. For treatment decisions, discuss your results with your GP.